Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma

por Franceschi, E, Cavallo, G, Scopece, L, Paioli, A, Pession, A, Magrini, E, Conforti, R, Palmerini, E, Bartolini, S, Rimondini, S, Esposti, R Degli, Crinò, L
Publicado 2004

No topoisomerase I alteration in a neuroblastoma model with in vivo acquired resistance to irinotecan

por Calvet, L, Santos, A, Valent, A, Terrier-Lacombe, M-J, Opolon, P, Merlin, J-L, Aubert, G, Morizet, J, Schellens, J H M, Bénard, J, Vassal, G
Publicado 2004

Abrogation of IL-6-mediated JAK signalling by the cyclopentenone prostaglandin 15d-PGJ(2) in oral squamous carcinoma cells

por Siavash, H, Nikitakis, N G, Sauk, J J
Publicado 2004

A novel 1p36.2 located gene, APITD1, with tumour-suppressive properties and a putative p53-binding domain, shows low expression in neuroblastoma tumours

por Krona, C, Ejeskär, K, Carén, H, Abel, F, Sjöberg, R-M, Martinsson, T
Publicado 2004

Frequent downregulation of 14-3-3 σ protein and hypermethylation of 14-3-3 σ gene in salivary gland adenoid cystic carcinoma

por Uchida, D, Begum, N-M, Almofti, A, Kawamata, H, Yoshida, H, Sato, M
Publicado 2004

Long-term outcome of radiological-guided insertion of implanted central venous access port devices (CVAPD) for the delivery of chemotherapy in cancer patients: institutional experi...

por Vardy, J, Engelhardt, K, Cox, K, Jacquet, J, McDade, A, Boyer, M, Beale, P, Stockler, M, Loneragan, R, Dennien, B, Waugh, R, Clarke, S J
Publicado 2004

Fulvestrant is an effective and well-tolerated endocrine therapy for postmenopausal women with advanced breast cancer: results from clinical trials

por Vergote, I, Robertson, J F R
Publicado 2004

Pre-operative urinary cathepsin D is associated with survival in patients with renal cell carcinoma

por Vasudev, N S, Sim, S, Cairns, D A, Ferguson, R E, Craven, R A, Stanley, A, Cartledge, J, Thompson, D, Selby, P J, Banks, R E
Publicado 2009

Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phase-III NO16966 tria...

por Okines, A, Puerto, O del, Cunningham, D, Chau, I, Van Cutsem, E, Saltz, L, Cassidy, J
Publicado 2009

Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement

por Foster, C S, Dodson, A R, Ambroisine, L, Fisher, G, Møller, H, Clark, J, Attard, G, De-Bono, J, Scardino, P, Reuter, V E, Cooper, C S, Berney, D M, Cuzick, J
Publicado 2009

VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo

por Rennel, E S, Varey, A H R, Churchill, A J, Wheatley, E R, Stewart, L, Mather, S, Bates, D O, Harper, S J
Publicado 2009

Serum triglyceride concentrations and cancer risk in a large cohort study in Austria

por Ulmer, H, Borena, W, Rapp, K, Klenk, J, Strasak, A, Diem, G, Concin, H, Nagel, G
Publicado 2009

Salivary analysis of oral cancer biomarkers

por Shpitzer, T, Hamzany, Y, Bahar, G, Feinmesser, R, Savulescu, D, Borovoi, I, Gavish, M, Nagler, R M
Publicado 2009

Design and modification of EGF4KDEL 7Mut, a novel bispecific ligand-directed toxin, with decreased immunogenicity and potent anti-mesothelioma activity

por Stish, B J, Oh, S, Chen, H, Dudek, A Z, Kratzke, R A, Vallera, D A
Publicado 2009

Atacicept in relapsed/refractory multiple myeloma or active Waldenström's macroglobulinemia: a phase I study

por Rossi, J-F, Moreaux, J, Hose, D, Requirand, G, Rose, M, Rouillé, V, Nestorov, I, Mordenti, G, Goldschmidt, H, Ythier, A, Klein, B
Publicado 2009

BRCA1 tumours correlate with a HIF-1α phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression

por Yan, M, Rayoo, M, Takano, E A, Thorne, H, Fox, S B
Publicado 2009

CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone

por Wasan, H S, Springett, G M, Chodkiewicz, C, Wong, R, Maurel, J, Barone, C, Rosbrook, B, Ricart, A D, Kim, S, Spano, J-P
Publicado 2009

Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker

por Munster, P N, Marchion, D, Thomas, S, Egorin, M, Minton, S, Springett, G, Lee, J-H, Simon, G, Chiappori, A, Sullivan, D, Daud, A
Publicado 2009

Direct cancer–stromal interaction increases fibroblast proliferation and enhances invasive properties of scirrhous-type gastric carcinoma cells

por Semba, S, Kodama, Y, Ohnuma, K, Mizuuchi, E, Masuda, R, Yashiro, M, Hirakawa, K, Yokozaki, H
Publicado 2009

Weekly administration of sagopilone (ZK-EPO), a fully synthetic epothilone, in patients with refractory solid tumours: results of a phase I trial

por Arnold, D, Voigt, W, Kiewe, P, Behrmann, C, Lindemann, S, Reif, S, Wiesinger, H, Giurescu, M, Thiel, E, Schmoll, H-J
Publicado 2009